郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Molecular interactions of progesterone derivatives with 5 alpha-reductase types 1 and 2 and androgen receptors.

期刊：Steroids发表年份：2010作者：Eugene Bratoeff; Perla García; Yvonne Heuze; Juan Soriano; Adriana Mejía; Ana María Labastida; Norma Valencia; Marisa Cabeza
阅读更多 →

药效评价Amyloid beta 42 peptide (Abeta42)-lowering compounds directly bind to Abeta and interfere with amyloid precursor protein (APP) transmembrane dimerization.

期刊：Proceedings of the National Academy of Sciences of the United States of America发表年份：2010作者：Luise Richter; Lisa-Marie Munter; Julia Ness; Peter W Hildebrand; Muralidhar Dasari; Stephanie Unterreitmeier; Bruno Bulic; Michael Beyermann; Ronald Gust; Bernd Reif; Sascha Weggen; Dieter Langosch; Gerd Multhaup
阅读更多 →

药效评价From anti-allergic to anti-Alzheimer's: Molecular pharmacology of Dimebon.

期刊：Current Alzheimer research发表年份：2010作者：I Okun; S E Tkachenko; A Khvat; O Mitkin; V Kazey; A V Ivachtchenko
阅读更多 →

药效评价L-stepholidine reduced L-DOPA-induced dyskinesia in 6-OHDA-lesioned rat model of Parkinson's disease.

期刊：Neurobiology of aging发表年份：2010作者：Jiao Mo; Hai Zhang; Lei-Ping Yu; Pei-Hua Sun; Guo-Zhang Jin; Xuechu Zhen
阅读更多 →